Carlyle Group is exploring an initial public offering in India for its healthcare revenue cycle management business. The private equity firm has invited investment banks to pitch for advisory roles on the potential listing, which follows the merger of Knack RCM and EqualizeRCM.
Carlyle's potential IPO highlights continued investor appetite for Indian healthcare listings, offering a potential exit for the private equity firm and a new investment opportunity in a resilient sector.
Carlyle Group Inc. is exploring the possibility of an initial public offering in India for its healthcare revenue cycle management (RCM) platform. The private equity firm has invited investment banks to present their pitches for advising on the potential listing.
The RCM business was recently formed through the merger of Knack RCM and EqualizeRCM, entities that Carlyle acquired last month. Banker presentations are currently underway, and Carlyle is expected to appoint advisers for the proposed share sale in the near future. Specific details regarding the IPO's size and valuation have not yet been disclosed.
This move comes at a time when the healthcare sector in India continues to attract investor interest for IPOs, even as the broader market has experienced a slowdown. Companies like Manipal Health Enterprises Ltd. and ASG Hospital Pvt. are also reportedly planning their own share sales. Knack RCM, based in Woodbridge, New Jersey, employs over 8,000 people across delivery centers in India, the Philippines, and the U.S., providing clinical, financial, and technology support to healthcare clients.